NCAM1 and cancer: Compared to female cancer patients, the male had more cell counts and higher percentage of CD16+CD56+ NK cells (P < 0.0001, Fig. 3A and B), but fewer cell counts and lower percentage of CD19+ B cells (P < 0.0001, Fig. 3C and D).